8-K: Aeluma Launches $50M At-The-Market Equity Offering

Aeluma, Inc. has entered into a sales agreement with several agents to potentially sell up to $50 million of its common stock through an at-the-market offering.

Summary

• Aeluma, Inc. (the "Company") entered into a Sales Agreement on March 20, 2026, with Roth Capital Partners, LLC, as representative of the agents, Craig-Hallum Capital Group LLC, Northland Securities, Inc., and The Benchmark Company, LLC.
• The agreement allows the Company to sell shares of its common stock, par value $0.0001 per share, having an aggregate sales price of up to $50.0 million.
• Sales will be made from time to time to or through the agents by means of ordinary brokers' transactions on the Nasdaq Capital Market at market prices or as otherwise agreed.
• The Company is not obligated to sell, and the agents are not obligated to buy or sell, any shares under the agreement.
• The offering is pursuant to the Company's shelf registration statement on Form S-3 (Registration No. 333-289135), which was declared effective by the SEC on August 8, 2025.
• The Company agreed to indemnify the agents against certain liabilities, including under the Securities Act of 1933 and the Securities Exchange Act of 1934.
• Either the Company or the agents may terminate the agreement upon 5 business days' prior written notice.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral development. While it provides financial flexibility and access to capital, the potential for future dilution could be a concern for existing shareholders, balancing the benefit of accessible capital.

Positives

• Provides Aeluma, Inc. with flexible access to capital of up to $50.0 million, which can be raised opportunistically to fund operations or strategic initiatives.
• The 'at-the-market' structure allows the company to issue shares over time, potentially minimizing immediate market impact compared to a single large offering.
• The absence of an obligation for the company to sell or the agents to buy offers discretion, allowing Aeluma to raise capital when market conditions are favorable or specific funding needs arise.

Negatives

• Potential for significant shareholder dilution if the full $50.0 million offering is completed, which could negatively impact earnings per share and existing ownership percentages.
• The continuous nature of an 'at-the-market' offering can create persistent, albeit gradual, downward pressure on the stock price due to the ongoing supply of new shares.
• Uncertainty regarding the timing, price, and number of shares that will actually be sold, making it difficult for investors to predict the full impact of the offering.

Risks

• No assurance can be given that the Company will sell any shares under the agreement, or, if it does, as to the price or number of shares that it sells or the dates when such sales will take place.
• The potential for dilution to existing shareholders if common stock is sold through the at-the-market offering.
• Market conditions or other factors could make it impractical or inadvisable for the agents to market the Placement Shares or to enforce contracts for their sale.

Future Outlook

The company has established a mechanism to potentially raise up to $50.0 million in capital through future sales of its common stock, providing flexibility for its financial needs without a firm commitment to sell. The specific use of proceeds will be as described in the prospectus.

Industry Context

StockSavvy.ai notes that at-the-market (ATM) offerings are a common strategy for companies, particularly those in growth phases, to efficiently raise capital over time. This method provides greater flexibility than traditional underwritten offerings, allowing companies to tap into market liquidity as needed and manage dilution more strategically. Competitors often utilize similar mechanisms to maintain financial agility and fund ongoing operations or strategic initiatives.

Comparison to Industry Standards

• The terms of this at-the-market offering, including the use of multiple agents and the discretionary nature of sales, are consistent with standard industry practices for public companies seeking flexible access to capital.
• No specific comparable companies, projects, or results are detailed within the filing to allow for a direct comparative assessment of the offering's potential impact relative to peers.

Stakeholder Impact

• Shareholders: Potential for dilution from new share issuances, which could impact per-share metrics, but also potential for increased capital to fund growth and operations.
• Company: Enhanced financial flexibility and access to capital for general corporate purposes, potentially reducing reliance on other, more restrictive financing methods.
• Agents: Opportunity to earn commissions on shares sold, benefiting from the transaction volume.

Next Steps

• The Company may issue Placement Notices to the agents to initiate sales of common stock under the agreement.
• The agents will use commercially reasonable efforts to sell Placement Shares according to the terms of any Placement Notice.
• Settlement for sales of Placement Shares will occur on the second trading day following the date on which such sales are made.
• The Company will file prospectus supplements with the SEC detailing the amount of Placement Shares sold, net proceeds, and compensation payable to the agents.

Key Dates

Recommendation

The at-the-market offering provides Aeluma with flexible access to capital, which is generally positive for funding operations or growth initiatives. However, the potential for future share dilution could exert downward pressure on the stock price, leading to a 'hold' recommendation as investors await clarity on the timing and extent of share issuances and the specific use of proceeds.

Keywords

Aeluma, ALMU, equity offering, at-the-market, ATM, capital raise, common stock, Nasdaq, Roth Capital Partners, Craig-Hallum Capital Group, Northland Securities, The Benchmark Company